Suppr超能文献

胎儿及成人肾脏中血管内皮生长因子/血管通透因子(VEGF/VPF)的受体:定位及[125I]VEGF结合位点

Receptors of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in fetal and adult human kidney: localization and [125I]VEGF binding sites.

作者信息

Simon M, Röckl W, Hornig C, Gröne E F, Theis H, Weich H A, Fuchs E, Yayon A, Gröne H J

机构信息

Institute of Pathology, Philipps University, Marburg, Germany.

出版信息

J Am Soc Nephrol. 1998 Jun;9(6):1032-44. doi: 10.1681/ASN.V961032.

Abstract

Vascular endothelial growth factor (VEGF) has an important function in renal vascular ontogenesis and is constitutively expressed in podocytes of the adult kidney. The ability of VEGF to be chemotactic for monocytes and to increase the activity of collagenase and plasminogen activator may have implications for renal development and renal disease. In humans, the cellular actions of VEGF depend on binding to two specific receptors: Flt-1 and KDR. The aims of this study were: (1) to localize VEGF receptor proteins in human renal ontogenesis; (2) to quantify VEGF binding in human fetal and adult kidney; and (3) to dissect the binding into its two known components: the KDR and Flt-1 receptors. The latter aim was achieved by competitive binding of VEGF and placenta growth factor-2, which only binds to Flt-1. Quantification of 125I-VEGF binding sites was performed by autoradiography and computerized densitometry. By double-label immunohistochemistry, VEGF receptor proteins were localized solely to endothelial cells of preglomerular vessels, glomeruli, and postglomerular vessels. In developing glomeruli, VEGF receptor protein appeared as soon as endothelial cells were positive for von Willebrand factor. Specific 125I-VEGF binding could be localized to renal arteries and veins, glomeruli, and the tubulointerstitial capillary network in different developmental stages. Affinity (Kd) of adult (aK) and fetal (fK) kidneys was: Kd: glomeruli 38.6 +/- 11.2 (aK, n = 5), 36.3 +/- 7.1 (fK, n = 5); cortical tubulointerstitium 19.4 +/- 2.6 (aK, n = 5), 11.6 +/- 7.0 (fK, n = 5) pmol. Placenta growth factor-2 displaced VEGF binding in all renal structures by approximately 60%. VEGF receptor proteins thus were found only in renal endothelial cells. A coexpression of both VEGF binding sites could be shown, with Flt-1 demonstrating the most abundant VEGF receptor binding sites in the kidney. These studies support the hypothesis of a function for VEGF in adult kidney that is independent of angiogenesis.

摘要

血管内皮生长因子(VEGF)在肾血管发生过程中具有重要作用,并且在成年肾脏的足细胞中持续表达。VEGF对单核细胞具有趋化作用,并能增加胶原酶和纤溶酶原激活剂的活性,这可能对肾脏发育和肾脏疾病产生影响。在人类中,VEGF的细胞作用取决于与两种特定受体的结合:Flt-1和KDR。本研究的目的是:(1)在人类肾脏发育过程中定位VEGF受体蛋白;(2)定量人类胎儿和成年肾脏中的VEGF结合;(3)将结合分解为其两个已知成分:KDR和Flt-1受体。通过VEGF与仅与Flt-1结合的胎盘生长因子-2的竞争性结合实现了后一个目标。通过放射自显影和计算机密度测定法对125I-VEGF结合位点进行定量。通过双重标记免疫组织化学,VEGF受体蛋白仅定位于肾小球前血管、肾小球和肾小球后血管的内皮细胞。在发育中的肾小球中,一旦内皮细胞对血管性血友病因子呈阳性,VEGF受体蛋白就会出现。特异性125I-VEGF结合可定位于不同发育阶段的肾动脉、静脉、肾小球和肾小管间质毛细血管网络。成年(aK)和胎儿(fK)肾脏的亲和力(Kd)为:Kd:肾小球38.6±11.2(aK,n = 5),36.3±7.1(fK,n = 5);皮质肾小管间质19.4±2.6(aK,n = 5),11.6±7.0(fK,n = 5)pmol。胎盘生长因子-2使所有肾脏结构中的VEGF结合位移约60%。因此,VEGF受体蛋白仅在肾内皮细胞中发现。可以显示两种VEGF结合位点的共表达,其中Flt-1在肾脏中显示出最丰富的VEGF受体结合位点。这些研究支持了VEGF在成年肾脏中具有独立于血管生成的功能这一假说。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验